NRG4 and type 2 diabetes mellitus: A cross-sectional study including 132 Chinese patients with T2DM demonstrated that serum Nrg4 levels were reduced in diabetic peripheral neuropathy (DPN) and significantly associated with its development, further implicating the anti-inflammatory and metabolic benefits of Nrg4 in T2DM (Yan et al., 2019).